Clinical Impact of Radical Resection of Synchronous and Metachronous Peritoneal Metastases from Colorectal Cancer.
暂无分享,去创建一个
S. Ito | Y. Shimizu | T. Abe | T. Kinoshita | Yusuke Sato | A. Ouchi | Aina Kunitomo | K. Komori | Tsuyoshi Sano
[1] J. Meyerhardt,et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.
[2] K. Sugihara,et al. Impact of R0 resection for synchronous peritoneal metastasis from colorectal cancer: A propensity score‐matched analysis of a multi‐institutional database , 2020, Annals of gastroenterological surgery.
[3] P. Gibbs,et al. Metastasectomy and BRAF mutation; an analysis of survival outcome in metastatic colorectal cancer. , 2020, Current problems in cancer.
[4] J. Mecklin,et al. Incidence and management of patients with colorectal cancer and synchronous and metachronous colorectal metastases: a population‐based study , 2020, BJS open.
[5] 大腸癌研究会. Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma: the 3d English Edition [Secondary Publication] , 2019, Journal of the anus, rectum and colon.
[6] Masahiro Yoshida,et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer , 2019, International Journal of Clinical Oncology.
[7] T. Pawlik,et al. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence. , 2018, Surgical oncology.
[8] M. Kendrick,et al. Impact of Metastasectomy in the Multimodality Approach for BRAF V600E Metastatic Colorectal Cancer: The Mayo Clinic Experience. , 2017, The oncologist.
[9] S. Ishihara,et al. Survival and Prognostic Factors for Metachronous Peritoneal Metastasis in Patients with Colon Cancer , 2017, Annals of Surgical Oncology.
[10] M. Ladanyi,et al. BRAF mutation predicts for poor outcomes after metastasectomy in patients with metastatic colorectal cancer , 2014, Cancer.
[11] K. Shirouzu,et al. Clinical benefit of surgery for stage IV colorectal cancer with synchronous peritoneal metastasis , 2014, Journal of Gastroenterology.
[12] W. Hohenberger,et al. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases , 2011, The British journal of surgery.
[13] Y. Kanemitsu,et al. Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy , 2017, Annals of Surgical Oncology.